312 related articles for article (PubMed ID: 27556298)
1. Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression.
Rovito D; Gionfriddo G; Barone I; Giordano C; Grande F; De Amicis F; Lanzino M; Catalano S; Andò S; Bonofiglio D
Oncotarget; 2016 Oct; 7(40):65109-65124. PubMed ID: 27556298
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Richard CL; Blay J
Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Catalano S; Gentile M; Middea E; Giordano F; Andò S
Clin Cancer Res; 2005 Sep; 11(17):6139-47. PubMed ID: 16144913
[TBL] [Abstract][Full Text] [Related]
5. 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways.
Richard CL; Lowthers EL; Blay J
Exp Cell Res; 2007 Oct; 313(16):3446-58. PubMed ID: 17707368
[TBL] [Abstract][Full Text] [Related]
6. PPARγ inhibits breast cancer progression by upregulating PTPRF expression.
Xu YY; Liu H; Su L; Xu N; Xu DH; Liu HY; Spaner D; Bed-David Y; Li YJ
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9965-9977. PubMed ID: 31799666
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma activates p53 gene promoter binding to the nuclear factor-kappaB sequence in human MCF7 breast cancer cells.
Bonofiglio D; Aquila S; Catalano S; Gabriele S; Belmonte M; Middea E; Qi H; Morelli C; Gentile M; Maggiolini M; Andò S
Mol Endocrinol; 2006 Dec; 20(12):3083-92. PubMed ID: 16887883
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
Bonofiglio D; Gabriele S; Aquila S; Qi H; Belmonte M; Catalano S; Andò S
Breast Cancer Res Treat; 2009 Feb; 113(3):423-34. PubMed ID: 18293083
[TBL] [Abstract][Full Text] [Related]
10. Glycolytic enzymes PGK1 and PKM2 as novel transcriptional targets of PPARγ in breast cancer pathophysiology.
Shashni B; Sakharkar KR; Nagasaki Y; Sakharkar MK
J Drug Target; 2013 Feb; 21(2):161-74. PubMed ID: 23130662
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
12. Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer.
Gionfriddo G; Plastina P; Augimeri G; Catalano S; Giordano C; Barone I; Morelli C; Giordano F; Gelsomino L; Sisci D; Witkamp R; Andò S; van Norren K; Bonofiglio D
Cells; 2020 Jan; 9(1):. PubMed ID: 31936729
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
Helbig G; Christopherson KW; Bhat-Nakshatri P; Kumar S; Kishimoto H; Miller KD; Broxmeyer HE; Nakshatri H
J Biol Chem; 2003 Jun; 278(24):21631-8. PubMed ID: 12690099
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.
Araki O; Ying H; Furuya F; Zhu X; Cheng SY
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16251-6. PubMed ID: 16260719
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Allred CD; Kilgore MW
Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
[TBL] [Abstract][Full Text] [Related]
17. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
18. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
[TBL] [Abstract][Full Text] [Related]
19. Heregulin/ErbB3 Signaling Enhances CXCR4-Driven Rac1 Activation and Breast Cancer Cell Motility via Hypoxia-Inducible Factor 1α.
Lopez-Haber C; Barrio-Real L; Casado-Medrano V; Kazanietz MG
Mol Cell Biol; 2016 Aug; 36(15):2011-26. PubMed ID: 27185877
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
